Does CABAZITAXEL Cause Prostate cancer metastatic? 74 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Prostate cancer metastatic have been filed in association with CABAZITAXEL (Jevtana). This represents 2.9% of all adverse event reports for CABAZITAXEL.
74
Reports of Prostate cancer metastatic with CABAZITAXEL
2.9%
of all CABAZITAXEL reports
9
Deaths
11
Hospitalizations
How Dangerous Is Prostate cancer metastatic From CABAZITAXEL?
Of the 74 reports, 9 (12.2%) resulted in death, 11 (14.9%) required hospitalization.
Is Prostate cancer metastatic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CABAZITAXEL. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does CABAZITAXEL Cause?
Febrile neutropenia (197)
Malignant neoplasm progression (172)
Fatigue (160)
Prostatic specific antigen increased (148)
Pyrexia (145)
Disease progression (143)
Diarrhoea (142)
Anaemia (127)
Neutropenia (126)
Drug ineffective (125)
What Other Drugs Cause Prostate cancer metastatic?
LEUPROLIDE (747)
ABIRATERONE (488)
DOCETAXEL (198)
ENZALUTAMIDE (165)
DENOSUMAB (144)
PREDNISONE (139)
RADIUM RA-223 DICHLORIDE (120)
BICALUTAMIDE (72)
ZOLEDRONIC ACID (71)
DEXAMETHASONE (59)
Which CABAZITAXEL Alternatives Have Lower Prostate cancer metastatic Risk?
CABAZITAXEL vs CABERGOLINE
CABAZITAXEL vs CABOTEGRAVIR
CABAZITAXEL vs CABOTEGRAVIR\RILPIVIRINE
CABAZITAXEL vs CABOZANTINIB
CABAZITAXEL vs CABOZANTINIB S-MALATE